These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1330 related articles for article (PubMed ID: 31863867)
1. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867 [TBL] [Abstract][Full Text] [Related]
2. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota. Shi G; Kong J; Wang Y; Xuan Z; Xu F J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029 [TBL] [Abstract][Full Text] [Related]
3. Sanhuang Xiexin decoction ameliorates DSS-induced colitis in mice by regulating intestinal inflammation, intestinal barrier, and intestinal flora. Wu X; Fu S; Jiang M; Wang J; Tang H; Fang C; Li W; Fu C J Ethnopharmacol; 2022 Oct; 297():115537. PubMed ID: 35843414 [TBL] [Abstract][Full Text] [Related]
4. Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice. Li C; Dong N; Wu B; Mo Z; Xie J; Lu Q Phytomedicine; 2021 Sep; 90():153631. PubMed ID: 34253428 [TBL] [Abstract][Full Text] [Related]
5. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades. Wang K; Guo J; Chang X; Gui S J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325 [TBL] [Abstract][Full Text] [Related]
6. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway. Fei L; Xu K J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656 [TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo. Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908 [TBL] [Abstract][Full Text] [Related]
8. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788 [TBL] [Abstract][Full Text] [Related]
9. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways. Li C; Liu M; Deng L; Luo D; Ma R; Lu Q Phytomedicine; 2023 Jul; 116():154899. PubMed ID: 37247589 [TBL] [Abstract][Full Text] [Related]
10. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis. Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J Front Immunol; 2021; 12():679897. PubMed ID: 34367139 [TBL] [Abstract][Full Text] [Related]
11. Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier. Yue B; Ren J; Yu Z; Luo X; Ren Y; Zhang J; Mani S; Wang Z; Dou W Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32687156 [TBL] [Abstract][Full Text] [Related]
12. Angelica sinensis aboveground part polysaccharide and its metabolite 5-MT ameliorate colitis via modulating gut microbiota and TLR4/MyD88/NF-κB pathway. Zou YF; Li CY; Fu YP; JiZe XP; Zhao YZ; Peng X; Wang JY; Yin ZQ; Li YP; Song X; Li LX; Zhao XH; Feng B; Huang C; Ye G; Tang HQ; Chen J; Li R; Chen XF; Tian ML Int J Biol Macromol; 2023 Jul; 242(Pt 1):124689. PubMed ID: 37148926 [TBL] [Abstract][Full Text] [Related]
13. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation. Li J; Zhong W; Wang W; Hu S; Yuan J; Zhang B; Hu T; Song G PLoS One; 2014; 9(2):e87810. PubMed ID: 24504372 [TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224 [TBL] [Abstract][Full Text] [Related]
17. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677 [TBL] [Abstract][Full Text] [Related]
18. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota. Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004 [TBL] [Abstract][Full Text] [Related]
19. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. Wang Y; Liu J; Huang Z; Li Y; Liang Y; Luo C; Ni C; Xie J; Su Z; Chen J; Li C Eur J Pharmacol; 2021 Apr; 896():173912. PubMed ID: 33508280 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of toll-like receptor 4 with TLR4-IN-C34 modulates the intestinal flora homeostasis and the MyD88/NF-κB axis in ulcerative colitis. Chen Y; Li D; Sun L; Qi K; Shi L Eur J Pharmacol; 2022 Nov; 934():175294. PubMed ID: 36152840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]